Cargando…
Mesenchymal stromal cells as potential immunomodulatory players in severe acute respiratory distress syndrome induced by SARS-CoV-2 infection
Severe acute respiratory syndrome coronavirus-2 and the related coronavirus disease-19 (COVID-19) is a worldwide emerging situation, which was initially reported in December 2019 in Wuhan, China. Currently, more than 7258842 new cases, and more than 411879 deaths have been reported globally. This ne...
Autores principales: | Mallis, Panagiotis, Michalopoulos, Efstathios, Chatzistamatiou, Theofanis, Stavropoulos-Giokas, Catherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477656/ https://www.ncbi.nlm.nih.gov/pubmed/32952855 http://dx.doi.org/10.4252/wjsc.v12.i8.731 |
Ejemplares similares
-
Evaluation of Peripheral Blood and Cord Blood Platelet Lysates in Isolation and Expansion of Multipotent Mesenchymal Stromal Cells
por: Christou, Ioanna, et al.
Publicado: (2018) -
Mesenchymal stromal cell delivery as a potential therapeutic strategy against COVID-19: Promising evidence from in vitro results
por: Mallis, Panagiotis, et al.
Publicado: (2022) -
Evaluation of HLA-G Expression in Multipotent Mesenchymal Stromal Cells Derived from Vitrified Wharton’s Jelly Tissue
por: Mallis, Panagiotis, et al.
Publicado: (2018) -
Introduction to the Special Issue on Stem Cell and Biologic Scaffold Engineering
por: Mallis, Panagiotis, et al.
Publicado: (2019) -
Modern Approaches in Cardiovascular Disease Therapeutics: From Molecular Genetics to Tissue Engineering
por: Mallis, Panagiotis, et al.
Publicado: (2021)